Life-Saving Mini Auto-Injector to Deliver Epinephrine
Award last edited on: 9/9/2023

Sponsored Program
Awarding Agency
Total Award Amount
Award Phase
Solicitation Topic Code
Principal Investigator
Stephen Harhen

Company Information

Rx Bandz LLC

1605 Lakecliff Lane Suite 100
Austin, TX 78732
   (617) 827-6253
Location: Single
Congr. District: 25
County: Travis

Phase I

Contract Number: FA8649-21-P-1166
Start Date: 4/14/2021    Completed: 7/19/2021
Phase I year
Phase I Amount
Rx Bandz’ innovative MiniJect™ auto-injector can be adapted to deliver epinephrine to Active Duty and beneficiaries prone to allergic reactions (anaphylaxis), as well as medics providing epinephrine when treating shock, cardiac arrest or respiratory distress. Its reduced size, weight, and ease-of-use means users can administer the right dose more reliably and quickly, no longer having to carry bulky, inconvenient auto-injectors. Furthermore, Rx Bandz’ epinephrine formulation aims to provide an increased shelf life over current auto-injectors.

Phase II

Contract Number: FA8649-22-P-0661
Start Date: 6/30/2022    Completed: 10/5/2023
Phase II year
Phase II Amount
Rx Bandz’ innovative MiniJect® auto-injector can be adapted to deliver epinephrine to thousands of Active Duty and beneficiaries prone to allergic reactions (anaphylaxis) as well as medics treating shock or respiratory distress. Currently, there is no comparable miniaturized Air Force or DoD solution/technology available. Modifications will be made for the Air Force specific requirement and to meet 810H Military Standards. Rx Bandz has validated proof of concept for the MiniJect® device as the world’s smallest auto-injector but must conduct Human Factors tests that capture AF requirements, labeling and user operations for FDA approval. Development and adaptations of the product will be verified and tested to meet the altering requirements provided by the AF customer. The tests will be performed using Rx Bandz MiniJect® auto-injector, designed for the civilian market. Human Factors are a critical step in commercialization for both military and civilian markets and required by the FDA.